Using anti-CD19 CAR T cells, severe and durable B cell depletion has been achieved not only in the periphery but also in the central nervous system, demonstrating that anti-CD19 CAR T cells may hold promise for patients with particular autoimmune disorders [99]. Here, CD19 is linked to autoimmune disease.